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Supplementary Methods
Reagents: Unless otherwise noted, all the materials were American Chemical Society grade or higher, and obtained from commercially available sources and were used without purification.
HPLC-grade solvents were purchased from Fisher Scientific (Pittsburgh, PA) and Sigma-Aldrich (Saint Louis, MO). Ultra dry DMSO was purchased from Acros Organics (Geel, Belgium).
Cy5.5 and Cy7 were purchased from GE Healthcare (Piscataway, NJ), while ZW800-1, ZW800-3C, and ZW800+3C were synthesized as previously reported. [1] [2] [3] KUE conjugation: Generally, the synthesis of the KUE-fluorophores involved one or two times activation of the carboxyl group for the subsequent conjugation. In our case, dipyrrolidino(N-succinimidyloxy)carbenium hexafluorophosphate (HSPyU) was utilized to generate the NHS ester forms of the NIR fluorophores in the presence of diisopropylethylamine (DIEA) in dimethyl sulfoxide (DMSO). The separation and purification of the NHS ester were performed smoothly by using simple precipitations in different solvents system, without the chromatographic process. The conjugation of KUE and PEG spacer with the NIR fluorophores had minimal impact on the spectral properties of each NIR fluorophore.
HPLC purification: HPLC purification of compounds was performed on a Waters (Milford, MA) prepHPLC 150 mL fluid handling unit equipped with a symmetry Prep C18 column (19 x 150 mm, 7 µm particle size), a dual-wavelength absorbance detector (254 and 700 nm), a manual injector (Rheodyme 3725i) and a 2487 dual wavelength absorbance detector outfitted with a semi-preparative flow cell. Solvent A was water with 0.1% formic acid and solvent B was absolute methanol 0.1% formic acid. The purification utilized a linear gradient from 10% to 90% solvent B over 30 min. Mobile phase flow rate was 15 mL/min.
ES-TOF mass spectroscopic analysis:
The purity of all compounds was measured using ultra-performance liquid chromatography (UPLC, Waters) combined with simultaneous ELSD, absorbance (photodiode array), fluorescence and electrospray time-of-flight (ES-TOF) mass spectrometry (MS). UPLC analyses were carried out using a Waters ACQUITY UPLC HSS C18 column (2.1x50 mm, 1.8 µm) and Xevo G2 QTof detector connected to a PC with a MassLynx 4.1 workstation. The mobile phase was solvent A = 0.1% formic acid in water, solvent B = 0.1% formic acid in methanol with a linear gradient from 10% to 90% (from A to B for 5 minutes).
The flow rate was 0.6 mL/min and all compounds were identified by mass to charge ratio. In vitro PSMA targeting assay: Human prostate cancer cells (PC-3 and LNCaP) were purchased from the ATCC (Manassas, VA). The cells lines were cultured at 37 °C, in a humidified atmosphere containing 5% CO 2 , in RPMI 1640 medium (Mediatech Cellgro) supplemented with 10% of fetal bovine serum (Gemini Biotech Products, Woodland, CA) and 5% of penicillin/streptomycin (Cambrex Bio Science, Walkersville, MD). Exponentially growing LNCaP and PC-3 cells at a confluence of 75% on glass coverslips were incubated for 60 min at 4 °C with 0.2 mL of TBS containing 2 µM of each fluorophore. The cells were washed three times with TBS, and imaged on a previously described four-channel NIR fluorescence microscope.
Physicochemical and optical property analyses:
In vivo biodistribution and clearance: Animals were housed in an AAALAC-certified facility and were studied under the supervision of BIDMC IACUC in accordance with the approved institutional protocol (#057-2014). Male CD-1 mice weighing roughly 20 g were purchased from
Charles River Laboratories (Wilmington, MA) and male NCr nu/nu mice 5 to 6 weeks of age weighing 22 g ± 3 g were purchased from Taconic Farms (Germantown, NY). Animals were anesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine intraperitoneally (Webster Veterinary, Fort Devens, MA). 10-25 nmol (0.4-1.0 mg/kg) of the NIR fluorophore conjugate in saline were administered intravenously, and animals were imaged with our real-time intraoperative imaging system. [4] [5] [6] [7] [8] [9] [10] In this study, 670 nm excitation and 760 nm excitation fluence rates used were 4.0 and 11.0 mW/cm 2 , respectively, with white light (400 to 650 nm) at 40,000 lx. Color video and 2 independent channels (700 nm and 800 nm) of NIR fluorescence images were acquired simultaneously with custom FLARE software at rates up to 15 Hz over a 15 cm diameter field of view (FOV). The imaging system was positioned at a distance of 18 inches from the surgical field. A custom filter set (Chroma Technology Corporation, Brattleboro, VT) composed of a 750 ± 25 nm excitation filter, a 785 nm dichroic mirror, and an 810 ± 20 nm emission filter were used to detect 800 nm fluorophores. For Cy5.5 detection, we used 650 ± 22 nm and 710 ± 25 nm excitation and emission filters. For each experiment, camera exposure time and image normalization was held constant. To quantify the blood clearance rate and urinary excretion, intermittent sampling from the tail vein was performed over the 4 h period following intravenous administration. Approximately 10-20 µL of blood were collected using glass capillary tubes at the following time points: 0, 1, 2, 5, 10, 15, 30, 60, 90, 120, 180, and 240 min.
Custom intraoperative fluorescence imaging system was used to measure the fluorescence intensity of each sample, and the concentration was calculated based on the image SBR using a standard curve for each fluorophore. To measure total body excretion in mice, animals were sacrificed at 30, and 240 min, and major tissues and organs were resected and imaged. Using capillary tubes, the amount of NIR fluorophore in each organ/tissue was quantified by measuring fluorescent intensity (photons/s/cm 2 /sr). 
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